Ethic Inc. grew its stake in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 14.5% in the third quarter, HoldingsChannel reports. The fund owned 2,388 shares of the medical instruments supplier’s stock after acquiring an additional 303 shares during the period. Ethic Inc.’s holdings in Mettler-Toledo International were worth $3,609,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Verus Capital Partners LLC raised its position in Mettler-Toledo International by 45.3% in the 3rd quarter. Verus Capital Partners LLC now owns 622 shares of the medical instruments supplier’s stock worth $940,000 after purchasing an additional 194 shares during the last quarter. Parallel Advisors LLC boosted its position in Mettler-Toledo International by 10.8% in the 3rd quarter. Parallel Advisors LLC now owns 318 shares of the medical instruments supplier’s stock valued at $481,000 after buying an additional 31 shares during the last quarter. Alta Advisers Ltd bought a new position in Mettler-Toledo International in the 3rd quarter valued at $218,000. Kestra Advisory Services LLC boosted its position in Mettler-Toledo International by 14.7% in the 3rd quarter. Kestra Advisory Services LLC now owns 506 shares of the medical instruments supplier’s stock valued at $765,000 after buying an additional 65 shares during the last quarter. Finally, Commonwealth Equity Services LLC increased its stake in shares of Mettler-Toledo International by 54.8% in the 3rd quarter. Commonwealth Equity Services LLC now owns 709 shares of the medical instruments supplier’s stock valued at $1,072,000 after buying an additional 251 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Mettler-Toledo International
In other news, CEO Patrick Kaltenbach sold 942 shares of the firm’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the transaction, the chief executive officer directly owned 4,480 shares in the company, valued at $6,384,000. This trade represents a 17.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Gerry Keller sold 435 shares of Mettler-Toledo International stock in a transaction on Monday, November 9th. The stock was sold at an average price of $1,734.05, for a total value of $754,311.75. Following the sale, the insider directly owned 259 shares of the company’s stock, valued at approximately $449,118.95. This trade represents a 62.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.71% of the company’s stock.
Key Headlines Impacting Mettler-Toledo International
- Positive Sentiment: Barclays raised its target from $1,700 to $1,900 and maintained an overweight rating; Stifel lifted its target from $1,600 to $1,900 and assigned a buy rating. Both targets imply further upside from the reference share price of $1,749.74. Barclays price target article Stifel price target article
- Neutral Sentiment: Robert W. Baird raised its target from $1,608 to $1,815 but kept a neutral rating. JPMorgan also retained a neutral rating despite lifting its target from $1,550 to $1,725. Goldman Sachs raised its target from $1,510 to $1,640, still below the reference share price—signaling that analyst views remain divided. Baird price target article Goldman Sachs price target article
- Negative Sentiment: Insider Gerry Keller sold 435 shares for about $754,000, reducing his direct holding by 62.68% to 259 shares. Insider sales can weigh on sentiment, though the filing alone does not indicate the reason for the transaction. SEC insider transaction filing
Mettler-Toledo International Trading Down 0.7%
Shares of NYSE MTD opened at $1,749.74 on Wednesday. The company’s 50 day simple moving average is $1,538.82 and its 200 day simple moving average is $1,349.09. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,806.58. The firm has a market capitalization of $34.80 billion, a P/E ratio of 38.06, a P/E/G ratio of 3.52 and a beta of 1.16. The company has a debt-to-equity ratio of 25.28, a current ratio of 1.10 and a quick ratio of 0.75.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $12.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $12.13 by $0.44. Mettler-Toledo International had a net margin of 22.25% and a return on equity of 15,012.71%. The firm had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.07 billion. During the same period last year, the firm earned $11.15 earnings per share. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts predict that Mettler-Toledo International, Inc. will post 47.83 EPS for the current year.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on MTD. UBS Group initiated coverage on Mettler-Toledo International in a research report on Wednesday, September 9th. They set a “neutral” rating and a $1,460.00 target price for the company. Barclays upped their price target on Mettler-Toledo International from $1,700.00 to $1,900.00 and gave the company an “overweight” rating in a research note on Monday. JPMorgan Chase & Co. raised their price target on Mettler-Toledo International from $1,550.00 to $1,725.00 and gave the company a “neutral” rating in a report on Monday. Jefferies Financial Group lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Finally, Weiss Ratings raised Mettler-Toledo International from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, October 19th. Six research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $1,595.77.
Check Out Our Latest Analysis on Mettler-Toledo International
Mettler-Toledo International Profile
Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes. The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.
Featured Articles
- Five stocks we like better than Mettler-Toledo International
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
